Today is September 23, 2024. All times in Eastern Daylight Time.
Datopotamab Deruxtecan Final Overall Survival Results Reported in Patients with Metastatic HR Positive, HER2 Low or Negative Breast Cancer in TROPION-Breast01 Phase 3 Trial
09/23/2024 - 02:00 AM
BUSINESS WIRE
Medincell’s Partner Teva Presented New Efficacy, Safety, and Tolerability Data from Pivotal Phase 3 of Olanzapine LAI for Adult Patients Diagnosed with Schizophrenia
09/23/2024 - 02:00 AM
BUSINESS WIRE
Wolters Kluwer Italia ottiene la certificazione per la parità di genere
09/23/2024 - 02:00 AM
BUSINESS WIRE
Medincell’s Partner Teva Provided Treatment Insights into Switching to UZEDY® from Perseris®
09/23/2024 - 02:00 AM
BUSINESS WIRE
Teva, partenaire de Medincell, a présenté de nouvelles données soutenant la transition de Perseris® à UZEDY® pour le traitement de la schizophrénie
09/23/2024 - 02:00 AM
BUSINESS WIRE
Sensorion annonce la mise à disposition de son Rapport du 1er semestre 2024
09/23/2024 - 01:31 AM
BUSINESS WIRE
Sensorion Announces the Availability of its Half Year 2024 Report
09/23/2024 - 01:31 AM
BUSINESS WIRE
Marqeta Announces Fouzi Husaini as Company’s Chief Artificial Intelligence Officer
09/23/2024 - 01:30 AM
BUSINESS WIRE
Sensorion annonce de nouveaux résultats cliniques positifs présentés lors du Congrès Mondial d'Audiologie
09/23/2024 - 01:30 AM
BUSINESS WIRE
Sensorion Reports New Positive Clinical Results Presented at the World Congress of Audiology
09/23/2024 - 01:30 AM
BUSINESS WIRE
1
...
5
6
7
8
9
10
11
12
13
14
15
...
1358
« Previous
Next »